Lori Dobson, MS, CGC
Lori Dobson, MS, CGC, is Assistant Professor in the School of Health and Rehabilitation Sciences and teaches in the Master of Science in Genetic Counseling program at MGH Institute of Health Professions. She is currently working at the Center for Fetal Medicine and Reproductive Genetics at Brigham and Women’s Hospital (BWH) as the Genetic Counseling Coordinator and Reproductive Genetic Counselor.
In her thirteen years as a reproductive genetic counselor, Ms. Dobson has worked in multiple service-delivery models involving prenatal and preconception genetics. She has extensive experience in clinical care including prenatal counseling for genetic conditions, providing families education and guidance in the setting of fetal diagnosis, and counseling for preimplantation genetic testing (PGT). She also has research experience in clinical and genetics laboratory settings.
BA, Psychology, with Honors, Minor, Allied Health, Westminster College, Fulton MO
MS, Genetic Counseling, with Honors, California State University, Northridge, CA
Reimers RM, Mason-Suares H, Little SE, Bromley B, Reiff ES, Dobson LJ, Wilkins-Haug L. When ultrasound anomalies are present: An estimation of the frequency of chromosome abnormalities not detected by cell free DNA aneuploidy screens. Prenat Diagn. 2018; epub ahead of print.
Lassey SC, Reiff ES, Dobson L, Bromley B, Wilkins-Haug L, Bartz D, Little SE. The influence of noninvasive prenatal testing on gestational age at time of abortion for aneuploidy. Prenat Diagn. 2017; 37(7):635-639.
Reiss RE, Discenza M, Foster J, Dobson L, Wilkins-Haug L. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous? Prenat Diagn. 2017; 37(5):515-520.
Dobson LJ, Reiff ES, Little SE, Wilkins-Haug L, Bromley B. Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA). Prenat Diagn. 2016; 36(5):456-62.
Reiff, ES, Little SE, Dobson L, Wilkins-Haug L, Bromley B. What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy? Prenat Diagn. 2016; 36(3):260-5.